ResMed Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 1.65 B

ResMed Inc. Operating Cash Flow is USD 1.65 B for the Trailing 12 Months (TTM) ending March 31, 2025, a 37.91% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • ResMed Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 1.20 B, a 123.89% change year over year.
  • ResMed Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 535.35 M, a 7.46% change year over year.
  • ResMed Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 498.19 M, a -40.72% change year over year.
  • ResMed Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 840.46 M, a 36.93% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities